227
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

A computational study on active constituents of Habb-ul-aas and Tabasheer as inhibitors of SARS-CoV-2 main protease

, , , , , , ORCID Icon, , , ORCID Icon, , & show all
Pages 7702-7713 | Received 15 Feb 2021, Accepted 04 Mar 2021, Published online: 24 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohd Shahnawaz Khan, Nojood Altwaijry, Moneera Saud Al-Bagmi, Nouf Omar Alafaleq, Majed S. Alokail, Moyad Shahwan & Anas Shamsi. (2023) Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Sali Abubaker Bagabir. (2023) Investigating the potential of natural compounds as novel inhibitors of SARS-CoV-2 RdRP using computational approaches. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-21.
Read now

Articles from other publishers (2)

Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Yinzhu Hou, Zuqing Liang, Luyu Qi, Chao Tang, Xingkai Liu, Jilin Tang, Yao Zhao, Yanyan Zhang, Tiantian Fang, Qun Luo, Shijun Wang & Fuyi Wang. (2022) Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways. Molecules 27:4, pages 1432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.